Słowa kluczowe
breast cancer
HDR
APBI
VAPBI
Jak cytować
Abstrakt
Celem artykułu jest przedstawienie najnowszych trendów i doniesień związanych z zastosowaniem brachyterapii w leczeniu raka piersi przedstawionych podczas 38 Konferencji Europejskiego Towarzystwa Radioterapii Onkologicznej (ang. European SocieTy for Radiotherapy and Oncology, ESTRO), która odbyła się w Mediolanie (Włochy) w dniach 26-30 kwietnia 2019 roku. W opracowaniu zawarte są informacje na temat przeprowadzonych sesji, sympozjów, debat, prezentacji ustnych oraz plakatowych wyróżnionych abstraktów dotyczących zastosowania brachyterapii w leczeniu raka piersi.
Bibliografia
Kaidar-Person O, Oldenborg S, Poortmans P. Re-irradiation and Hyperthermia in Breast Cancer. Clin Oncol (R Coll Radiol) 2018 Feb;30(2):73-84.
Forster T, Akbaba S, Schmitt D, et al. Second breast conserving therapy after ipsilateral breast tumor recurrence – a 10-year experience of re-irradiation. Journal of Contemporary Brachytherapy. 2019;11(4):312-319.
Cozzi S, Jamal D, Slocker A, et al. Second breast-concerving therapy with interstitial brachytherapy (APBI) as a salvage treatment in ipsilateral breast tumor recurrence: a retrospective study of 40 patients. J Contemp Brachytherapy 2019;11(2):101-107.
Hannoun-Levi JM, Resch A, Gal A, et al. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol 2013 Aug;108(2):226-31.
OC-0318 10-year clinical and cosmetic outcomes of high-dose-rate brachytherapy for early breast cancer. Radiat Oncol 2019, Vol. 133 (Suppl. 1):S165.
OC-0319 Twelve years clinical outcomes with APBI with interstitial multicatheter brachytherapy after BCS. Radiat Oncol 2019, Vol. 133 (Suppl. 1):S165.
Guinot J, Gonzalez-Perez V, Meszaros N et al. OC-0321 Phase I-II multicenter trial Very Accelerated Partial Breast Irradiation (VAPBI): early effects. Radiat Oncol 2019, Vol. 133 (Suppl. 1):S166.
Strnad V, Ott OJ, Hildebrandt G, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 2016 Jan 16; 387(10015):229-38.
SP-0343 Postoperative multicatheter brachytherapy. Radiat Oncol 2019, Vol. 133 (Suppl. 1):S173.
SP-0345 Single catheter balloon brachytherapy (Mammosite, Contura). Radiat Oncol 2019, Vol. 133 (Suppl. 1):S174.
SP-0346 Single catheter brachytherapy (SAVI) - Pitfalls, results and current recommendations. Radiat Oncol 2019, Vol. 133 (Suppl. 1):S174.
Coles CE, Griffin CL, Kirby AM, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breats cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlle, phase 2, non-inferiority trial. Lancet 2017 Sep 9;390(10099):1048-1060.
SP-0492 Radiobiology of APBI: aspects and limitations. Radiat Oncol 2019, Vol. 133 (Suppl. 1):S252.
EP-2119 HDR BRT boost in breast cancer: postoperative vs intraoperative procedurę, long-term outcomes. Radiat Oncol 2019, Vol. 133 (Suppl. 1):S1173.
EP-2123 APBI with Interstitial Brachytherapy versus Whole-Breast Irradiation for Early-Stage Breast Cancer. Radiat Oncol 2019, Vol. 133 (Suppl. 1):S1174.
EP-2118 Effects of interfraction uncertainty with Strut Adjusted Volune Implant applicator. Radiat Oncol 2019, Vol. 133 (Suppl. 1):S1172.